re: frankfurt - kesmet so? the fact that it goes up or dn make diff to sp on ASX and it is not supposed to mirror the sp on other xchanges thats how i interpret it
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025